核酸医薬品の世界市場洞察、2031年までの予測

世界の核酸医薬品市場は、予測期間中に年平均成長率（CAGR）7.43%で成長し、2024年の1億4,636万米ドルから2031年には2億1,722万米ドルに達すると予測されています。

本レポートは、核酸医薬品の世界市場の概要と市場規模を概観しています。世界の市場動向を分析し、2020年～2024年の市場収益の過去データ、2025年の予測、そして2031年までのCAGR（年平均成長率）予測を提示しています。

本レポートでは、核酸医薬品の主要メーカーを調査し、主要地域および国の収益も提供しています。核酸医薬品の今後の市場ポテンシャル、そして市場を様々なセグメントおよびサブセグメントに分類するための主要地域/国についても重点的に分析しています。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国について、国別データと市場価値分析を提供しています。

このレポートでは、2020年から2031年までのセグメントデータをタイプ別、アプリケーション別、収益および成長率別に分析します。核酸医薬品の収益、予測される成長傾向、生産技術、アプリケーションおよびエンドユーザー産業の市場規模を評価および予測します。

Report Overview

The global Nucleic Acid Drugs market is projected to grow from US$ 14636 million in 2024 to US$ 21722 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.43% during the forecast period.

The North America market for Nucleic Acid Drugs is estimated to increase from $ 8327.53 million in 2024 to reach $ 11827 million by 2031, at a CAGR of 6.4% during the forecast period of 2025 through 2031.

The China market for Nucleic Acid Drugs is estimated to increase from $ 81.1 million in 2024 to reach $ 1231.84 million by 2031, at a CAGR of 44.83% during the forecast period of 2025 through 2031.

The Europe market for Nucleic Acid Drugs is estimated to increase from $ 3316.94 million in 2024 to reach $ 6063.24 million by 2031, at a CAGR of 10.64% during the forecast period of 2025 through 2031.

The global key companies of Nucleic Acid Drugs include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, etc. In 2024, the global top five players had a share approximately 86.47% in terms of revenue.

Report Includes

This report presents an overview of global market for Nucleic Acid Drugs market size. Analyses of the global market trends, with historic market revenue data for 2020 – 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nucleic Acid Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nucleic Acid Drugs revenue, market share and industry ranking of main companies, data from 2020 to 2024. Identification of the major stakeholders in the global Nucleic Acid Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Nucleic Acid Drugs revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, etc.

Market Segmentation

By Company

On Market Company

•                 Sarepta Therapeutics
•                 Ionis Pharmaceuticals
•                 Alnylam
•                 Biogen
•                 Nippon Shinyaku
•                 Sobi
•                 Novartis
•                 BioNTech
•                 Pfizer
•                 Moderna Therapeutics
•                 Jazz Pharmaceuticals
•                 Novo Nordisk
•                 AstraZeneca
•                 Astellas Pharma

On Pipeline Company

•                 CureVac
•                 Regulus Therapeutics
•                 ProQR
•                 Secarna
•                 MiNA Therapeutics
•                 Sylentis
•                 Arrowhead
•                 Silence Therapeutics

Segment by Type

•                 Antisense Oligonucleotides (ASO)
•                 siRNA
•                 mRNA

Segment by Application

•                 Neuromuscular Diseases
•                 hATTR
•                 COVID-19
•                 Other

By Region

North America

•                 United States
•                 Canada

China

Asia-Pacific

•                 Japan
•                 South Korea
•                 Southeast Asia
•                 India
•                 Australia
•                 Rest of Asia

Europe

Germany

•                 France
•                 U.K.
•                 Italy
•                 Russia
•                 Rest of Europe

Latin America

•                 Mexico
•                 Brazil
•                 Rest of Latin America

Middle East & Africa

•                 Middle East
•                 Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Nucleic Acid Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nucleic Acid Drugs companies‘ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Drugs revenue, gross margin, and recent development, etc.

Chapter 12: Analyst’s Viewpoints/Conclusions

Table of Contents

1 Report Overview                1

1.1 Study Scope    1

1.2 Market Analysis by Type               1

1.2.1 Global Nucleic Acid Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031  1

1.2.2 Antisense Oligonucleotides (ASO)          3

1.2.3 siRNA           5

1.2.4 mRNA           6

1.3 Market by Application  7

1.3.1 Global Nucleic Acid Drugs Market Share by Application: 2020 VS 2024 VS 2031        8

1.3.2 Neuromuscular Diseases           10

1.3.3 hATTR         10

1.3.4 COVID-19   11

1.4 Assumptions and Limitations       12

1.5 Study Objectives            13

1.6 Years Considered           14

2 Global Growth Trends     15

2.1 Global Nucleic Acid Drugs Market Perspective (2020-2031)                 15

2.2 Global Nucleic Acid Drugs Growth Trends by Region            16

2.2.1 Global Nucleic Acid Drugs Market Size by Region: 2020 VS 2024 VS 2031        17

2.2.2 Nucleic Acid Drugs Market Size by Region (2020-2031)     18

2.3 Nucleic Acid Drugs Market Dynamics       20

2.3.1 Nucleic Acid Drugs Industry Trends       20

2.3.2 Nucleic Acid Drugs Market Drivers        21

2.3.3 Nucleic Acid Drugs Market Challenges  22

2.3.4 Nucleic Acid Drugs Market Restraints    22

3 Competition Landscape by Key Players        24

3.1 Global Revenue Nucleic Acid Drugs by Players        24

3.1.1 Global Nucleic Acid Drugs Revenue by Players (2020-2025)                 24

3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Players (2020-2025)      25

3.2 Global Nucleic Acid Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)             26

3.3 Global Key Players of Nucleic Acid Drugs, Ranking by Revenue, 2023 VS 2024 VS 2025  27

3.4 Global Market Concentration Ratio            28

3.4.1 Global Nucleic Acid Drugs Market Concentration Ratio (CR5 and HHI)       28

3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Drugs Revenue in 2024   29

3.5 Global Key Players of Nucleic Acid Drugs Head office and Area Served                 30

3.6 Global Key Players of Nucleic Acid Drugs, Product and Application                 31

3.7 Global Key Players of Nucleic Acid Drugs, Date of Enter into This Industry 33

3.8 Mergers & Acquisitions, Expansion Plans 33

4 Breakdown Data by Type                 37

4.1 Global Nucleic Acid Drugs Historic Market Size by Type (2020-2025)                 37

4.2 Global Nucleic Acid Drugs Forecasted Market Size by Type (2026-2031)      38

5 Breakdown Data by Application     39

5.1 Global Nucleic Acid Drugs Historic Market Size by Application (2020-2025)      39

5.2 Global Nucleic Acid Drugs Forecasted Market Size by Application (2026-2031)           40

6 North America   41

6.1 North America Nucleic Acid Drugs Market Size (2020-2031)                 41

6.2 North America Market Size by Type           41

6.2.1 North America Nucleic Acid Drugs Market Size by Type (2020-2031)      41

6.2.2 North America Nucleic Acid Drugs Market Share by Type (2020-2031)      42

6.3 North America Market Size by Application               43

6.3.1 North America Nucleic Acid Drugs Market Size by Application (2020-2031)           43

6.3.2 North America Nucleic Acid Drugs Market Share by Application (2020-2031)           44

6.4 North America Market Size by Country     44

6.4.1 North America Nucleic Acid Drugs Market Size by Country: 2020 VS 2024 VS 2031        44

6.4.2 North America Nucleic Acid Drugs Market Size by Country (2020-2031)      45

6.4.3 United States               46

6.4.4 Canada          46

7 Europe 47

7.1 Europe Nucleic Acid Drugs Market Size (2020-2031)             47

7.2 Europe Market Size by Type        47

7.2.1 Europe Nucleic Acid Drugs Market Size by Type (2020-2031)                 47

7.2.2 Europe Nucleic Acid Drugs Market Share by Type (2020-2031)                 48

7.3 Europe Market Size by Application             48

7.3.1 Europe Nucleic Acid Drugs Market Size by Application (2020-2031)                 48

7.3.2 Europe Nucleic Acid Drugs Market Share by Application (2020-2031)      49

7.4 Europe Market Size by Country  50

7.4.1 Europe Nucleic Acid Drugs Market Size by Country: 2020 VS 2024 VS 2031  50

7.4.2 Europe Nucleic Acid Drugs Market Size by Country (2020-2025)                 50

7.4.3 Germany      52

7.4.4 France           52

7.4.5 U.K.               53

7.4.6 Italy               53

7.4.7 Russia           54

8 China  55

8.1 China Nucleic Acid Drugs Market Size (2020-2031)                55

8.2 China Market Size by Type          55

8.2.1 China Nucleic Acid Drugs Market Size by Type (2020-2031)                 55

8.2.2 China Nucleic Acid Drugs Market Share by Type (2020-2031)                 56

8.3 China Market Size by Application               57

8.3.1 China Nucleic Acid Drugs Market Size by Application (2020-2031)                 57

8.3.2 China Nucleic Acid Drugs Market Share by Application (2020-2031)                 58

9 Asia (excluding China)     59

9.1 Asia Nucleic Acid Drugs Market Size (2020-2031)  59

9.2 Asia Market Size by Type             59

9.2.1 Asia Nucleic Acid Drugs Market Size by Type (2020-2031)                 59

9.2.2 Asia Nucleic Acid Drugs Market Share by Type (2020-2031)                 60

9.3 Asia Market Size by Application 61

9.3.1 Asia Nucleic Acid Drugs Market Size by Application (2020-2031)                 61

9.3.2 Asia Nucleic Acid Drugs Market Share by Application (2020-2031)                 62

9.4 Asia Market Size by Region          62

9.4.1 Asia Nucleic Acid Drugs Market Size by Region: 2020 VS 2024 VS 2031        62

9.4.2 Asia Nucleic Acid Drugs Market Size by Region (2020-2031)                 63

9.4.3 Japan             64

9.4.4 South Korea 65

9.4.5 Southeast Asia             65

9.4.6 India              66

9.4.7 Australia       66

10 Middle East, Africa, and Latin America      67

10.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size (2020-2031)  67

10.2 Middle East, Africa, and Latin America Market Size by Type                 67

10.2.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2020-2031)   67

10.2.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2020-2031)                 68

10.3 Middle East, Africa, and Latin America Market Size by Application                 69

10.3.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2020-2031)        69

10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)     70

10.4 Middle East, Africa, and Latin America Market Size by Country                 70

10.4.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country: 2020 VS 2024 VS 2031          70

10.4.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2020-2031)              71

10.4.3 Brazil          72

10.4.4 Mexico        72

10.4.5 Middle East                73

10.4.6 Africa          73

11 Key Players Profiles        74

11.1 Sarepta Therapeutics  74

11.1.1 Sarepta Therapeutics Company Details                74

11.1.2 Sarepta Therapeutics Business Overview             74

11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Introduction    75

11.1.4 Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)           76

11.1.5 Sarepta Therapeutics Recent Development         76

11.2 Ionis Pharmaceuticals 77

11.2.1 Ionis Pharmaceuticals Company Details               77

11.2.2 Ionis Pharmaceuticals Business Overview            77

11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Introduction   78

11.2.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025)           80

11.2.5 Ionis Pharmaceuticals Recent Development        80

11.3 Alnylam         81

11.3.1 Alnylam Company Details      81

11.3.2 Alnylam Business Overview    81

11.3.3 Alnylam Nucleic Acid Drugs Introduction           82

11.3.4 Alnylam Revenue in Nucleic Acid Drugs Business (2020-2025)                 83

11.3.5 Alnylam Recent Development                84

11.4 Biogen            84

11.4.1 Biogen Company Details         84

11.4.2 Biogen Business Overview      85

11.4.3 Biogen Nucleic Acid Drugs Introduction              85

11.4.4 Biogen Revenue in Nucleic Acid Drugs Business (2020-2025)                 87

11.4.5 Biogen Recent Development  87

11.5 Nippon Shinyaku         88

11.5.1 Nippon Shinyaku Company Details      88

11.5.2 Nippon Shinyaku Business Overview    89

11.5.3 Nippon Shinyaku Nucleic Acid Drugs Introduction            89

11.5.4 Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2020-2025)      90

11.5.5 Nippon Shinyaku Recent Development                90

11.6 Sobi                91

11.6.1 Sobi Company Details             91

11.6.2 Sobi Business Overview           91

11.6.3 Sobi Nucleic Acid Drugs Introduction  92

11.6.4 Sobi Revenue in Nucleic Acid Drugs Business (2020-2025)                 93

11.6.5 Sobi Recent Development       93

11.7 Novartis         93

11.7.1 Novartis Company Details      93

11.7.2 Novartis Business Overview   94

11.7.3 Novartis Nucleic Acid Drugs Introduction           94

11.7.4 Novartis Revenue in Nucleic Acid Drugs Business (2020-2025)                 95

11.7.5 Novartis Recent Development                95

11.8 BioNTech     96

11.8.1 BioNTech Company Details  96

11.8.2 BioNTech Business Overview                 96

11.8.3 BioNTech Nucleic Acid Drugs Introduction        97

11.8.4 BioNTech Revenue in Nucleic Acid Drugs Business (2020-2025)                 97

11.8.5 BioNTech Recent Development             98

11.9 Pfizer              98

11.9.1 Pfizer Company Details           98

11.9.2 Pfizer Business Overview        99

11.9.3 Pfizer Nucleic Acid Drugs Introduction                99

11.9.4 Pfizer Revenue in Nucleic Acid Drugs Business (2020-2025)                 100

11.9.5 Pfizer Recent Development    100

11.10 Moderna Therapeutics              101

11.10.1 Moderna Therapeutics Company Details           101

11.10.2 Moderna Therapeutics Business Overview        102

11.10.3 Moderna Therapeutics Nucleic Acid Drugs Introduction                 102

11.10.4 Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)           103

11.10.5 Moderna Therapeutics Recent Development    103

11.11 Jazz Pharmaceuticals 104

11.11.1 Jazz Pharmaceuticals Company Details              104

11.11.2 Jazz Pharmaceuticals Business Overview           104

11.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Introduction  105

11.11.4 Jazz Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025)           106

11.11.5 Jazz Pharmaceuticals Recent Development       107

11.12 Novo Nordisk             107

11.12.1 Novo Nordisk Company Details          107

11.12.2 Novo Nordisk Business Overview        108

11.12.3 Novo Nordisk Nucleic Acid Drugs Introduction                108

11.12.4 Novo Nordisk Revenue in Nucleic Acid Drugs Business (2020-2025)      109

11.12.5 Novo Nordisk Recent Development    109

11.13 AstraZeneca                110

11.13.1 AstraZeneca Company Details             110

11.13.2 AstraZeneca Business Overview          111

11.13.3 AstraZeneca Nucleic Acid Drugs Introduction 111

11.13.4 AstraZeneca Revenue in Nucleic Acid Drugs Business (2020-2025)      112

11.13.5 AstraZeneca Recent Development      112

11.14 Astellas Pharma         113

11.14.1 Astellas Pharma Company Details      113

11.14.2 Astellas Pharma Business Overview    113

11.14.3 Astellas Pharma Nucleic Acid Drugs Introduction            114

11.14.4 Astellas Pharma Revenue in Nucleic Acid Drugs Business (2020-2025)      115

11.14.5 Astellas Pharma Recent Development                115

11.15 CureVac      115

11.15.1 CureVac Company Details   115

11.15.2 CureVac Business Overview 116

11.15.3 CureVac Nucleic Acid Drugs Introduction        116

11.15.4 CureVac Recent Development             117

11.16 Regulus Therapeutics                118

11.16.1 Regulus Therapeutics Company Details             118

11.16.2 Regulus Therapeutics Business Overview          118

11.16.3 Regulus Therapeutics Nucleic Acid Drugs Introduction 119

11.16.4 Regulus Therapeutics Recent Development      119

11.17 ProQR         120

11.17.1 ProQR Company Details      120

11.17.2 ProQR Business Overview    120

11.17.3 ProQR Nucleic Acid Drugs Introduction           121

11.17.4 ProQR Recent Development                121

11.18 Secarna        122

11.18.1 Secarna Company Details     122

11.18.2 Secarna Business Overview  122

11.18.3 Secarna Nucleic Acid Drugs Introduction          123

11.18.4 Secarna Recent Development               123

11.19 MiNA Therapeutics  124

11.19.1 MiNA Therapeutics Company Details                124

11.19.2 MiNA Therapeutics Business Overview             125

11.19.3 MiNA Therapeutics Nucleic Acid Drugs Introduction    125

11.19.4 MiNA Therapeutics Recent Development         126

11.20 Sylentis        126

11.20.1 Sylentis Company Details     126

11.20.2 Sylentis Business Overview  127

11.20.3 Sylentis Nucleic Acid Drugs Introduction          127

11.20.4 Sylentis Recent Development               128

11.21 Arrowhead  128

11.21.1 Arrowhead Company Details                128

11.21.2 Arrowhead Business Overview             129

11.21.3 Arrowhead Nucleic Acid Drugs Introduction    129

11.21.4 Arrowhead Recent Development         130

11.22 Silence Therapeutics 130

11.22.1 Silence Therapeutics Company Details              130

11.22.2 Silence Therapeutics Business Overview            130

11.22.3 Silence Therapeutics Nucleic Acid Drugs Introduction   131

11.22.4 Silence Therapeutics Recent Development        132

12 Analyst’s Viewpoints/Conclusions                133

13 Appendix          135

13.1 Research Methodology                135

13.1.1 Methodology/Research Approach         135

13.1.2 Data Source               138

13.2 Author Details              141

13.3 Disclaimer    141

Tables and Figures

Table 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031             1

Table 2. Global Nucleic Acid Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031             8

Table 3. Global Nucleic Acid Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031                17

Table 4. Global Market Size by Region (2020-2025) & (US$ Million)                 18

Table 5. Global Market Size by Region (2026-2031) & (US$ Million)                 18

Table 6. Global Nucleic Acid Drugs Market Share by Region (2020-2025)                 19

Table 7. Global Nucleic Acid Drugs Market Share by Region (2026-2031)                 19

Table 8. Market Trends       20

Table 9. Market Drivers      21

Table 10. Market Challenges              22

Table 11. Market Restraints                22

Table 12. Global Nucleic Acid Drugs Revenue by Players (2020-2025) & (US$ Million)        24

Table 13. Global Nucleic Acid Drugs Market Share by Players (2020-2025)      25

Table 14. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2024) 26

Table 15. Global Nucleic Acid Drugs Industry Ranking 2023 VS 2024                 27

Table 16. Global 5 Largest Players Market Share by Nucleic Acid Drugs Revenue (CR5 and HHI) & (2020-2025)          29

Table 17. Global Key Players of Nucleic Acid Drugs, Headquarters and Area Served           30

Table 18. Global Key Players of Nucleic Acid Drugs, Product and Application            31

Table 19. Global Key Players of Nucleic Acid Drugs, Date of Enter into This Industry         33

Table 20. Mergers & Acquisitions, Expansion Plans      33

Table 21. Global Market Size by Type (2020-2025) & (US$ Million)                 37

Table 22. Global Nucleic Acid Drugs Revenue Market Share by Type (2020-2025)           37

Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)        38

Table 24. Global Nucleic Acid Drugs Revenue Market Share by Type (2026-2031)           38

Table 25. Global Market Size by Application (2020-2025) & (US$ Million)                 39

Table 26. Global Nucleic Acid Drugs Revenue Market Share by Application (2020-2025)     39

Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)        40

Table 28. Global Nucleic Acid Drugs Revenue Market Share by Application (2026-2031)     40

Table 29. North America Market Size by Type (2020-2025) & (US$ Million)        41

Table 30. North America Market Size by Type (2026-2031) & (US$ Million)        42

Table 31. North America Market Size by Application (2020-2025) & (US$ Million)        43

Table 32. North America Market Size by Application (2026-2031) & (US$ Million)        43

Table 33. North America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031              44

Table 34. North America Market Size by Country (2020-2025) & (US$ Million)        45

Table 35. North America Market Size by Country (2026-2031) & (US$ Million)        45

Table 36. Europe Market Size by Type (2020-2025) & (US$ Million)                 47

Table 37. Europe Market Size by Type (2026-2031) & (US$ Million)                 48

Table 38. Europe Market Size by Application (2020-2025) & (US$ Million)        48

Table 39. Europe Market Size by Application (2026-2031) & (US$ Million)        49

Table 40. Europe Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031             50

Table 41. Europe Market Size by Country (2020-2025) & (US$ Million)                 50

Table 42. Europe Market Size by Country (2026-2031) & (US$ Million)                 51

Table 43. China Market Size by Type (2020-2025) & (US$ Million)                 55

Table 44. China Market Size by Type (2026-2031) & (US$ Million)                 56

Table 45. China Market Size by Application (2020-2025) & (US$ Million)                 57

Table 46. China Market Size by Application (2026-2031) & (US$ Million)                 57

Table 47. Asia Market Size by Type (2020-2025) & (US$ Million)                 59

Table 48. Asia Market Size by Type (2026-2031) & (US$ Million)                 60

Table 49. Asia Market Size by Application (2020-2025) & (US$ Million)                 61

Table 50. Asia Market Size by Application (2026-2031) & (US$ Million)                 61

Table 51. Asia Nucleic Acid Drugs Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031             62

Table 52. Asia Market Size by Region (2020-2025) & (US$ Million)                 63

Table 53. Asia Market Size by Region (2026-2031) & (US$ Million)                 63

Table 54. Middle East, Africa, and Latin America Market Size by Type (2020-2025) & (US$ Million)            67

Table 55. Middle East, Africa, and Latin America Market Size by Type (2026-2031) & (US$ Million)            68

Table 56. Middle East, Africa, and Latin America Market Size by Application (2020-2025) & (US$ Million)       69

Table 57. Middle East, Africa, and Latin America Market Size by Application (2026-2031) & (US$ Million)       69

Table 58. Middle East, Africa, and Latin America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031                 70

Table 59. Middle East, Africa, and Latin America Market Size by Country (2020-2025) & (US$ Million)            71

Table 60. Sarepta Therapeutics Company Details          74

Table 61. Sarepta Therapeutics Business Overview       74

Table 62. Sarepta Therapeutics Nucleic Acid Drugs Product       75

Table 63. Sarepta Therapeutics Revenue (2020-2025) & (US$ Million)                 76

Table 64. Sarepta Therapeutics Recent Development   76

Table 65. Ionis Pharmaceuticals Company Details         77

Table 66. Ionis Pharmaceuticals Business Overview      77

Table 67. Ionis Pharmaceuticals Nucleic Acid Drugs Product      78

Table 68. Ionis Pharmaceuticals Revenue (2020-2025) & (US$ Million)                 80

Table 69. Ionis Pharmaceuticals Recent Development  80

Table 70. Alnylam Company Details 81

Table 71. Alnylam Business Overview              81

Table 72. Alnylam Nucleic Acid Drugs Product              82

Table 73. Alnylam Revenue (2020-2025) & (US$ Million)           83

Table 74. Alnylam Recent Development          84

Table 75. Biogen Company Details   84

Table 76. Biogen Business Overview                 85

Table 77. Biogen Nucleic Acid Drugs Product                85

Table 78. Biogen Revenue (2020-2025) & (US$ Million)             87

Table 79. Biogen Recent Development             87

Table 80. Nippon Shinyaku Company Details 88

Table 81. Nippon Shinyaku Business Overview               89

Table 82. Nippon Shinyaku Nucleic Acid Drugs Product              89

Table 83. Nippon Shinyaku Revenue (2020-2025) & (US$ Million)                 90

Table 84. Nippon Shinyaku Recent Development          90

Table 85. Sobi Company Details       91

Table 86. Sobi Business Overview     91

Table 87. Sobi Nucleic Acid Drugs Product    92

Table 88. Sobi Revenue (2020-2025) & (US$ Million) 93

Table 89. Sobi Recent Development 93

Table 90. Novartis Company Details                 93

Table 91. Novartis Business Overview              94

Table 92. Novartis Nucleic Acid Drugs Product             94

Table 93. Novartis Revenue (2020-2025) & (US$ Million)          95

Table 94. Novartis Recent Development          95

Table 95. BioNTech Company Details             96

Table 96. BioNTech Business Overview           96

Table 97. BioNTech Nucleic Acid Drugs Product          97

Table 98. BioNTech Revenue (2020-2025) & (US$ Million)       97

Table 99. BioNTech Recent Development       98

Table 100. Pfizer Company Details  98

Table 101. Pfizer Business Overview                99

Table 102. Pfizer Nucleic Acid Drugs Product                99

Table 103. Pfizer Revenue (2020-2025) & (US$ Million)             100

Table 104. Pfizer Recent Development            100

Table 105. Moderna Therapeutics Company Details     101

Table 106. Moderna Therapeutics Business Overview  102

Table 107. Moderna Therapeutics Nucleic Acid Drugs Product  102

Table 108. Moderna Therapeutics Revenue (2020-2025) & (US$ Million)                 103

Table 109. Moderna Therapeutics Recent Development               103

Table 110. Jazz Pharmaceuticals Company Details        104

Table 111. Jazz Pharmaceuticals Business Overview     104

Table 112. Jazz Pharmaceuticals Nucleic Acid Drugs Product     105

Table 113. Jazz Pharmaceuticals Revenue (2020-2025) & (US$ Million)                 106

Table 114. Jazz Pharmaceuticals Recent Development 107

Table 115. Novo Nordisk Company Details    107

Table 116. Novo Nordisk Business Overview  108

Table 117. Novo Nordisk Nucleic Acid Drugs Product 108

Table 118. Novo Nordisk Revenue (2020-2025) & (US$ Million)                 109

Table 119. Novo Nordisk Recent Development               109

Table 120. AstraZeneca Company Details       110

Table 121. AstraZeneca Business Overview    111

Table 122. AstraZeneca Nucleic Acid Drugs Product    111

Table 123. AstraZeneca Revenue (2020-2025) & (US$ Million) 112

Table 124. AstraZeneca Recent Development 112

Table 125. Astellas Pharma Company Details 113

Table 126. Astellas Pharma Business Overview               113

Table 127. Astellas Pharma Nucleic Acid Drugs Product              114

Table 128. Astellas Pharma Revenue (2020-2025) & (US$ Million)                 115

Table 129. Astellas Pharma Recent Development          115

Table 130. CureVac Company Details              115

Table 131. CureVac Business Overview           116

Table 132. CureVac Nucleic Acid Drugs Product           116

Table 133. CureVac Recent Development       117

Table 134. Regulus Therapeutics Company Details       118

Table 135. Regulus Therapeutics Business Overview    118

Table 136. Regulus Therapeutics Nucleic Acid Drugs Product    119

Table 137. Regulus Therapeutics Recent Development                 119

Table 138. ProQR Company Details 120

Table 139. ProQR Business Overview              120

Table 140. ProQR Nucleic Acid Drugs Product              121

Table 141. ProQR Recent Development          121

Table 142. Secarna Company Details                122

Table 143. Secarna Business Overview             122

Table 144. Secarna Nucleic Acid Drugs Product            123

Table 145. Secarna Recent Development         123

Table 146. MiNA Therapeutics Company Details          124

Table 147. MiNA Therapeutics Business Overview       125

Table 148. MiNA Therapeutics Nucleic Acid Drugs Product       125

Table 149. MiNA Therapeutics Recent Development   126

Table 150. Sylentis Company Details                126

Table 151. Sylentis Business Overview             127

Table 152. Sylentis Nucleic Acid Drugs Product             127

Table 153. Sylentis Recent Development         128

Table 154. Arrowhead Company Details          128

Table 155. Arrowhead Business Overview       129

Table 156. Arrowhead Nucleic Acid Drugs Product       129

Table 157. Arrowhead Recent Development   130

Table 158. Silence Therapeutics Company Details        130

Table 159. Silence Therapeutics Business Overview      130

Table 160. Silence Therapeutics Nucleic Acid Drugs Product     131

Table 161. Silence Therapeutics Recent Development  132

Table 162. Research Programs/Design for This Report                 135

Table 163. Key Data Information from Secondary Sources           139

Table 164. Key Data Information from Primary Sources               140

List of Figures

Figure 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)              2

Figure 2. Global Nucleic Acid Drugs Market Share by Type: 2024                 3

Figure 3. Global Nucleic Acid Drugs Market Share by Type: 2031                 3

Figure 4. Antisense Oligonucleotides (ASO) Features  4

Figure 5. siRNA Features    6

Figure 6. mRNA Features   7

Figure 7. Global Nucleic Acid Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)        8

Figure 8. Global Nucleic Acid Drugs Market Share by Application: 2024                 9

Figure 9. Global Nucleic Acid Drugs Market Share by Application: 2031                 9

Figure 10. Neuromuscular Diseases Case Studies           10

Figure 11. hATTR Case Studies        11

Figure 12. COVID-19 Case Studies  12

Figure 13. Nucleic Acid Drugs Report Years Considered              14

Figure 14. Global Nucleic Acid Drugs Market Size (US$ Million), Year-over-Year: 2020-2031           15

Figure 15. Global Nucleic Acid Drugs Market Size, (US$ Million), 2020 VS 2025 VS 2031  16

Figure 16. Global Nucleic Acid Drugs Market Share by Region: 2024 VS 2031        17

Figure 17. Global Nucleic Acid Drugs Market Share by Region: 2024 VS 2031        18

Figure 18. Global Nucleic Acid Drugs Market Share by Players in 2024                 26

Figure 19. The Top 5 Players Market Share by Nucleic Acid Drugs Revenue in 2024   29

Figure 20. The Top 10 Players Market Share by Nucleic Acid Drugs Revenue in 2024   30

Figure 21. North America Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)            41

Figure 22. North America Nucleic Acid Drugs Market Share by Type (2020-2031)           42

Figure 23. North America Nucleic Acid Drugs Market Share by Application (2020-2031)     44

Figure 24. North America Nucleic Acid Drugs Market Share by Country (2020-2031)           45

Figure 25. United States Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)            46

Figure 26. Canada Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        46

Figure 27. Europe Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        47

Figure 28. Europe Nucleic Acid Drugs Market Share by Type (2020-2031)                 48

Figure 29. Europe Nucleic Acid Drugs Market Share by Application (2020-2031)      49

Figure 30. Europe Nucleic Acid Drugs Market Share by Country (2020-2031)      51

Figure 31. Germany Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        52

Figure 32. France Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        52

Figure 33. U.K. Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)   53

Figure 34. Italy Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)   53

Figure 35. Russia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        54

Figure 36. China Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        55

Figure 37. China Nucleic Acid Drugs Market Share by Type (2020-2031)                 56

Figure 38. China Nucleic Acid Drugs Market Share by Application (2020-2031)      58

Figure 39. Asia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)   59

Figure 40. Asia Nucleic Acid Drugs Market Share by Type (2020-2031)                 60

Figure 41. Asia Nucleic Acid Drugs Market Share by Application (2020-2031)      62

Figure 42. Asia Nucleic Acid Drugs Market Share by Region (2020-2031)                 64

Figure 43. Japan Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        64

Figure 44. South Korea Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)            65

Figure 45. Southeast Asia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)            65

Figure 46. India Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        66

Figure 47. Australia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        66

Figure 48. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)               67

Figure 49. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2020-2031)  68

Figure 50. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Application (2020-2031)       70

Figure 51. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2026-2031) & (US$ Million) 71

Figure 52. Brazil Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        72

Figure 53. Mexico Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        72

Figure 54. Middle East Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)            73

Figure 55. Africa Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)        73

Figure 56. Bottom-up and Top-down Approaches for This Report                 137

Figure 57. Data Triangulation            138

Figure 58. Key Executives Interviewed              140

QYResearchは広範な市場を対象にし、多様な市場調査レポートを出版している中国北京に本社をおく市場調査会社です。QYResearch出版の市場調査レポートに関するご質問やサンプルページのご依頼等はいつでもお気軽にお問合せください。

QYResearch 出版レポート一覧

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイル閲覧可のライセンスです。
    • 提供ファイルはPDFファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • マルチユーザライセンス
    • 同一企業内10名までレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • エンタープライズライセンス
    • 同一企業および関連会社内において人数無制限でレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
• 納期
  • 既刊レポート：ご注文後3営業日以内
  • オンデマンドレポート：通常7営業日前後

• 納品形態
  • Eメール

注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでのご注文をお待ちしております。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。